TRVI - Company ID 0001563880
The table below shows Trevi Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $18.91M | $34.10M | $32.40M | $12.59M | $36.83M | $45.00M |
| Short-term investments | $169.35M | $73.53M | $50.57M | $107.92M | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $191.66M |
| $109.43M |
| $87.55M |
| $122.62M |
| $37.96M |
| $46.27M |
| Property, plant & equipment | $178.00K | $157.00K | $216.00K | $170.00K | $53.00K | $103.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $193.44M | $110.90M | $89.40M | $123.02M | $38.48M | $47.13M |
| Accounts payable | $3.91M | $3.41M | $1.81M | $2.86M | $2.85M | $2.02M |
| Total current liabilities | $9.75M | $10.51M | $5.82M | $13.40M | $12.72M | $5.55M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $10.20M | $11.26M | $6.86M | $15.56M | $21.40M | - |
| Retained earnings | -$329.80M | -$287.05M | -$239.13M | -$210.07M | -$180.92M | -$146.98M |
| Total equity | $183.24M | $99.64M | $82.55M | $107.46M | $17.07M | $27.28M |